BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Karyopharm Therapeutics 



Newton  Massachusetts    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Biotechnology






 Company News
Karyopharm Therapeutics (KPTI) Announces Initiation Of A Phase 1 Study Of Decitabine (Dacogen®) And Selinexor (KPT-330) In Acute Myeloid Leukemia (AML) 4/16/2014 9:32:40 AM    More...
Karyopharm Therapeutics (KPTI) Appoints Chris Primiano as General Counsel 4/11/2014 8:02:55 AM    More...
Karyopharm Therapeutics (KPTI) Enters Into Preferred Provider Agreement With Clinipace Inc. 4/9/2014 9:09:46 AM    More...
Karyopharm Therapeutics (KPTI) To Present At 13th Annual Needham Healthcare Conference 4/9/2014 8:56:20 AM    More...
Karyopharm Therapeutics (KPTI) Reports 2013 Year-End Financial Results And Provides Update On Clinical Development Plans 3/5/2014 9:21:00 AM    More...
Karyopharm Therapeutics (KPTI) Announces Nine Presentations On Its Selective Inhibitors Of Nuclear Export (SINE) Compounds And PAK4 Inhibitors At The American Association for Cancer Research Meeting 2/27/2014 9:30:22 AM    More...
Karyopharm Therapeutics (KPTI) Announces Initiation Of An Investigator Sponsored Phase 1 Dose Escalation Study Of Its Lead Drug Candidate Selinexor (KPT-330) In Singapore 2/27/2014 9:16:07 AM    More...
Karyopharm Therapeutics (KPTI) To Present At Upcoming Healthcare Conferences In February 2/6/2014 9:20:34 AM    More...
Karyopharm Therapeutics (KPTI) Presents Clinical Data On Selinexor (KPT-330) In Colorectal Cancer From Ongoing Phase 1 Study And Preclinical Data On Novel PAK4 Inhibitors At American Society of Clinical Oncology 2014 Gastrointestinal Cancers Symposium 1/22/2014 8:49:15 AM    More...
Karyopharm Therapeutics (KPTI) Announces Data Presentations At American Society of Clinical Oncology Annual Gastrointestinal Cancers Symposium 1/14/2014 9:06:34 AM    More...
12345